HealthMed Corp -The Power of Prevention
We redirect the potency of prescriptions, harvesting them for power in prevention
HealthMed is a new generation pharmaceutical company, dedicated to developing healthier medicines. HM-100, a "polypill" for the primary prevention of cardiovascular disease, is on track for FDA 505(b)(2) approval. Our timeline includes FDA-based Three-Year Exclusivity for an NDA that contains sponsored clinical studies essential to its approval, and Priority Review for an NDA that contains evidence of likely improvements in medication adherence.